Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01948297
Title Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Debiopharm International SA
Indications

Advanced Solid Tumor

Therapies

Debio 1347

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute Boston Massachusetts 02114 United States Details
Massachusetts General Hospital Boston Massachusetts 02215 United States Details
Memorial Sloan-Kettering Hospital New York New York 10065 United States Details
The University of Texas; MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
National Cancer Center Singapore Singapore 169610 Singapore Details
Vall d'Hebron University Hospital Barcelona Spain Details
Taipei Medical University Hospital Taipei 11031 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field